The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer

BACKGROUND: Several classification systems are available to assess pathological response to neoadjuvant chemotherapy in breast cancer, but reliable biomarkers to predict the efficiency of primary systemic therapy (PST) are still missing. Deregulation of gap junction channel forming connexins (Cx) ha...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Teleki, Ivett, Krenacs, Tibor, Szasz, Marcell A, Kulka, Janina, Wichmann, Barna, Leo, Cornelia, Papassotiropoulos, Barbel, Riemenschnitter, Cosima, Moch, Holger, Varga, Zsuzsanna
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2013
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3583680/
https://ncbi.nlm.nih.gov/pubmed/23374644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-50
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak